The Indian government has restricted exports of 13 health care products including acetaminophen, B-complex vitamins, birth control and antibiotics in both powder and pill formats. It’s not clear how the restriction will work but it is arguably one of the most significant non-China supply chain disruptions since the COVID-19 outbreak. Indian exports of the products covered fell 33.6% year over year in the 12 months to Nov. 30. Exports to the U.S. – which represented 11.9% of the total Indian exports including shipments by Sun Pharma and Granules India – were an outlie...